RVUs are a useful gauge of doctors' productivity, but practices also should look at such aspects as each practitioner's caseload and reimbursements.
Distinguishing primary from secondary focal segmental glomerulosclerosis is crucial because the treatment approaches and therapeutic goals differ.
We crave clinical and scientific data, yet we grieve the performance-based data increasingly directed toward us.
Growing a practice is a matter of knowing your market and reaching out to referral sources and patients.
Dr. Moe spoke about the importance of nephrology research and how a prize competition can facilitate the process.
Dialysis is not necessarily in the patient's best interest, clinicians and ethicists say.
Many patients still insist that I need to check and manage their cholesterol.
As we move to a more comprehensive model, it makes sense to diminish the separation between the clinical and administrative sides of practice.
Jonathan Harper, MD, of the UW School of Medicine in Seattle, explains his "Rolling Stones" concept as a feasible office procedure.
Confirmation of creatinine-based eGFR should be performed in select circumstances using, where appropriate, either measured GFR or cystatin C.
For the first time, the federal CMS has made public a database showing what it pays out to individual physicians.
Coloplast has been involved in the manufacturing of inflatable penile prosthesis since 1973.
Out-of-pocket is one option, but it may make better business sense to lease equipment or borrow money to pay for it.
CORAL study chair Lance Dworkin, MD, discusses the controversial finding with Renal & Urology News.
Human beings are unique in the animal kingdom when it comes to nutrition.
Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.
Nephrologists and urologists can spend more time providing quality care for patients, but establishing referral sources may be a challenge.
Rising readmission rates of subsequent sepsis have given urologic surgeon Jeremy Grummet, MBBS, MS, FRACS, pause.
The term "personalized medicine" remains an overused promise to apply specific treatment plans.
In-house clinics can be a cost-efficient way to provide high-quality healthcare, without having to make a large investment.
Immunologic mismatch may no longer be a barrier between living kidney donors and recipients.
Geriatric patients with CKD are at high risk for morbidity and mortality from the potential side effects of treatments.
A majority of patients on HD have hypertension, and CVD is the leading cause of death in these patients.
This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.
Although several biomarkers show promise, PCA3 has garnered substantial attention following FDA approval and its role in the diagnosis of PCa will grow.
Elevated levels of Hcy are associated with increased levels of cardiovascular inflammation.
Medical office staff need to understand which patients often miss their appointments and why.
The surgical treatment of urolithiasis has undergone a marked evolution over the past 30 years.
Some may find it surprising that Dr. Critz generally considers RP to be the go-to treatment for localized disease.
When we move from one state to another, typically we must obtain a driver's license from the state to which we are relocating.
Sensitivity to the price of medications, for example, may improve patient adherence to pharmacotherapy.
A digital sensing platform could allow patients with chronic kidney ailments or diabetes to test their own urine albumin levels.
As a venue for presenting important research on kidney disease to the world, Kidney Week never disappoints.
Innovative approaches offer the potential for effective treatments to limited target areas with improved side effect profiles.
Clinicians will use neurostimulation, mobile apps, portable dialysis, artificial kidneys, and remote monitoring in innovative ways.
Urologist Ronald K. Loo, MD, of Southern California Permanente Medical Group and colleagues created and validated a Hematuria Risk Index.
Vitamin D is often recognized for its impact on bone metabolism, but it is also an important regulator of immune function.
After the end of 16-day federal shutdown in October, media headlines touted the financial impact on America and the cost of restarting the government.
Elderly patients face greater perioperative risks and postoperative mortality, so careful selection of surgical candidates is imperative.
Physicians need to know such particulars as what they pay per square foot for office space and the cost per minute of patient care.
Hyponatremia authority Dr. Juan Carlos Ayus receives calls all the time from fellow nephrologists who have questions.
For years, dietary recommendations have focused on reducing saturated fat and its potential sources.
Over the past 10 years the annual ESRD incidence rate per million U.S. population has remained stagnant or even shown sporadic downward trends.
The type and amount of ingested protein affects clinical outcomes such as protein-energy wasting, kidney function and even survival.
Cultivate good referral relationships and prove to payers that you provide high-quality, cost-effective care.
Radium-223 was approved in May 2013 for the treatment of mCRPC with symptomatic bone metastases and no visceral disease.
Keeping abreast of the most current treatments for idiopathic OAB can lead to improved outcomes and quality of life.
Elevated uric acid levels are associated with increased risks for hypertension, gout, and renal impairment.
For men at risk of developing prostate cancer (PCa), prophylactic prostatectomy seems almost irrational for several reasons
These mid-level healthcare providers make it possible to increase caseload and free up doctors so they can focus on higher-cost services.
A nascent technology combines laser optics and ultrasound to distinguish between benign and malignant prostate tissue.
Specialists must work with primary care doctors and other healthcare providers to ensure cost-effective delivery of medical services.
The Mediterranean diet is getting more attention because of its long-term benefits in terms of overall mortality and CVD risk.
Once again, a study offers evidence that one of the keys to good nutrition is avoiding excess.
Dr. Crispen highlights the advantages and challenges of active surveillance for small renal masses.
The benefits of omega-3 (n-3) fatty acids in renal populations were last discussed in this column in 2007.
In the nephrology community, there have been heightened discussions and apparent enthusiasm about the revival of PD as the prototype for home dialysis.
The first step in prevention is adequate and quantitative counseling regarding fluid intake, which is effective and inexpensive.
Live like a medical resident for a while and save a minimum of 15% of your income throughout your career, financial planners advise.
David O. Sussman, DO, has been ready to educate urology colleagues on the appropriate use of Botox.
The vow never to treat SRMs may seem hard to believe and self-defeating.
Zinc supplementation has been shown to decrease levels of plasma aluminum and reactive oxygen species in dialysis patients.
While bone loss and reduction in bone mineral density are well known consequences of ADT, the main concern is increased risk of osteoporotic fractures.
Strategies to maintain a competitive and healthy practice include getting patients involved in their own care and learning about sources of patient referrals and income.
The MENTOR study is poised to change first-line-treatment recommendations for idiopathic membranous nephropathy.
Two studies presented at the recent NKF Spring Clinical Meetings provide more evidence of a trend toward decreasing use of ESAs and decreasing hemoglobin levels.
Ghrelin is metabolized by the kidney; thus serum levels are elevated in chronic kidney disease populations.
Treatment of LUTS secondary to BPH has evolved from surgical therapy to medical monotherapy, and now combination therapy.
Compliance gurus bet there are at least a few things physicians are not doing to comply with HIPAA.
Provenge is a breatkthrough treatment option for men with asymptomatic or minimally symptomatic metastatic, hormone-resistant PCa.
Questions have been raised as to whether leptin has an impact on malnutrition in this population.
Having just returned from the always-stimulating European Association of Urology annual congress, I'd like to share a few impressions.
Given the frequency with which these lesions are found, urologists and nephrologists should be familiar with their evaluation.
Studies have shown that group therapy can be at least as effective as individual treatment.
The scar tissue that forms on sections of some glomeruli in FSGS will lead to kidney failure if left untreated.
Many but not all cohort studies examining the relationship between hyperuricemia and CKD outcomes suggest they may be intertwined.
Foods that may increase gout flare risk are also dietary factors that may promote further kidney decline in individuals with CKD stages 3-5.
Almost half a million Americans depend on chronic dialysis therapy to survive.
Emerging data suggest that thyroid hormone deficiency may be associated with greater cardiovascular morbidity and mortality in this population.
A number of new diagnostic and therapeutic tools have emerged in the field of glomerular diseases.
In both nutritional and activated forms, vitamin D may have side effects that are as yet under-appreciated.
A major consideration is the new relationship specialists will have with primary care providers.
Ringing in the new year was especially exciting this time around for Ashutosh K. Tewari, MB, BS, head of the new Center for Prostate Cancer at New York-Presbyterian.
Dyslipidemia often is a concern in patients with CKD because mortality in this population typically is the result of cardiovascular complications.
Obese individuals often are rejected as renal transplant candidates in large part because of their increased risk for surgical complications and adverse outcomes.
Physicians are more often defined by their ability to diagnose, treat, and research a disease than their willingness to manage its spectrum of risk.
Urologists typically treat a renal cortical mass without biopsy, but this should be re-evaluated in the era of the incidental small renal cortical neoplasm.
Fee-for-service will be a mainstay of reimbursement, but insurers may increasingly move toward a pay-for-performance model.
The incidence of AKI requiring dialysis is now higher than the incidence of ESRD requiring dialysis or transplant.
How often have you met for business in a Starbucks, Coffee Bean, or any other coffee shop?
Age and physical activity have profound effects on the accrual and retention of lean body tissues, but a range of nutritional factors can influence this process.
Scientific speculation suggests that uremic toxins, viral mediators, and immune inhibition could play a role in malignant transformation.
Doctors have to figure out how to work smarter, not harder.
A promising hybrid device that works from the inside to provide renal functions beyond dialysis 24 hours a day, seven days a week, has the potential to change a lot of lives.
The Cleveland Clinic has initiated the collection and storage of biospecimens from kidney and pancreas transplant recipients.
Testosterone deficiency is common in many patients with CKD, but the treatment of this deficiency and associated side effects have not always received much attention.
Kidney Week 2012, held in San Diego, is now history and as usual I like to reflect on the world's biggest and most prestigious meeting for kidney specialists.
It is hoped that selective screening, selective biopsy, and selective therapy will further decrease the morbidity associated with screening.
Technology can help, but increasing productivity is often a low-tech process requiring just a little bit of dedicated time and energy.
More than 100,000 patients are on the kidney transplant waiting list and the increasing number of patients without living donor options underscore why it is important to decrease the discard rate of deceased donor kidneys available for transplantation.